Feng Jiang

Member of the Henry Ford Cancer Institute

I specialize in Neurology and Research.

PharmD., Pharmaceutical Chemistry, Beijing Medical University, Beijing, P.R. China 1987
PostD., Cancer Pharmacology, Dept of Neurosurgery, Henry Ford Hospital, Detroit, MI 1993-1995
PostD., Cancer Pharmacology, Dept of Neurology, Henry Ford Hospital, Detroit, MI 1995-2000

Research Interests:
Experimental therapeutical studies: study the glioma response to photodynamic therapy, anti-angiogenic therapy and gene therapy.
Neurotoxicity studies: Study the neurotoxicity induced by glioma growth and the therapies.

Awards and Honors:

• 2006 Henry Ford Hospital Internal Funding Reviewer
• 2008 National Institute of Health Discovery and Development P01 Special Emphasis Panel
• 2008 Henry Ford Hospital Internal Funding Reviewer
• 2009 National Institute of Health Special Emphasis Panel, ZRG1 IMM-G (02) M
• 2009 Scotland, Biomedical and Therapeutic Research Committee, Advisor on the funding of biomedical research in Scotland
• 2010 NIH DT Study Selection